Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 2, 2011
Angiotensin II receptor activation in youth triggers persistent insulin resistance and hypertension--a legacy effect?Nobuhiko Togashi, Takuto Maeda, Hideaki Yoshida, et al.
Heart and Vessels|July 30, 2014
Cardiac tamponade leading to the diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literatureToshiyuki Yano, Shutaro Ishimura, Tetsuaki Furukawa, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 30, 2023
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analysesKazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
European Heart Journal Open|August 3, 2022
High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general populationYukimura Higashiura, Marenao Tanaka, Kazuma Mori, et al.
Metabolites|March 24, 2022
Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without MedicationMasato Furuhashi, Yukimura Higashiura, Akiko Sakai, et al.
Clinical Kidney Journal|September 26, 2022
Increased LDL-cholesterol level is associated with deterioration of renal function in malesArata Osanami, Marenao Tanaka, Masato Furuhashi, et al.
Clinical and Experimental Nephrology|May 20, 2022
Clinical and pathological characteristics of patients with acute kidney injury in Japan in whom kidney biopsy was performed: a cross-sectional analysis of the Japan Renal Biopsy Registry (J‑RBR)Norihito Moniwa, Marenao Tanaka, Hiroshi Sato, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 2003
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertensionMasato Furuhashi, Nobuyuki Ura, Katsuhiro Higashiura, et al.
Plos One|April 29, 2016
Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 InhibitorMasato Furuhashi, Megumi Matsumoto, Shinya Hiramitsu, et al.
Journal of Diabetes Investigation|December 10, 2021
Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individualsMarenao Tanaka, Satoko Takahashi, Yukimura Higashiura, et al.
Pageof 11